Xiufeng Hu
No.127 Dongming Road
Zhengzhou, 450001, China
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Dose-response relationship of pre-ICU corticosteroids and influenza-associated pulmonary aspergillosis: a multicenter target trial emulation.
Journal: Annals of intensive care
Published: May 20, 2026
Early antifungal prophylaxis fails to prevent influenza-associated pulmonary aspergillosis in the ICU: a target trial emulation.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 27, 2026
First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis.
Journal: Frontiers in oncology
Published: November 22, 2024
Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 Study.
Journal: Clinical lung cancer
Published: October 31, 2024
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: January 10, 2024
Case Report: PD-1 Inhibitor Is Active in Lung Adenocarcinoma With B Cell Deficiency.
Journal: Frontiers in immunology
Published: May 19, 2020
Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1.
Journal: Cell death & disease
Published: February 17, 2020
Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 30, 2019
LncRNA TDRG1 promotes the metastasis of NSCLC cell through regulating miR-873-5p/ZEB1 axis.
Journal: Journal of cellular biochemistry
Published: July 04, 2019
Last Updated: 09/26/2026